Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Chen

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Diabetes|December 29, 2005
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db miceThomas Harrity, Dennis Farrelly, Aaron Tieman, et al.
Journal of Medicinal Chemistry|March 18, 2005
Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activitiesPratik V Devasthale, Sean Chen, Yoon Jeon, et al.
ACS Medicinal Chemistry Letters|June 22, 2016
Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARα Selective AgonistYan Shi, Jun Li, Lawrence J Kennedy, et al.
Nature Cancer|January 29, 2024
Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activationMeri Rogava, Tyler J Aprati, Wei-Yu Chi, et al.
Journal of Medicinal Chemistry|March 12, 2010
Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453)Jun Li, Lawrence J Kennedy, Yan Shi, et al.
Journal of Medicinal Chemistry|February 18, 2022
Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1<i>H</i>-pyrazol-1-yl)methyl)phosphonate (BMS-820132)Yan Shi, Ying Wang, Wei Meng, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Diabetes|December 29, 2005
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db miceThomas Harrity, Dennis Farrelly, Aaron Tieman, et al.
Journal of Medicinal Chemistry|March 18, 2005
Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activitiesPratik V Devasthale, Sean Chen, Yoon Jeon, et al.
ACS Medicinal Chemistry Letters|June 22, 2016
Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARα Selective AgonistYan Shi, Jun Li, Lawrence J Kennedy, et al.
Nature Cancer|January 29, 2024
Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activationMeri Rogava, Tyler J Aprati, Wei-Yu Chi, et al.
Journal of Medicinal Chemistry|March 12, 2010
Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453)Jun Li, Lawrence J Kennedy, Yan Shi, et al.
Journal of Medicinal Chemistry|February 18, 2022
Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1<i>H</i>-pyrazol-1-yl)methyl)phosphonate (BMS-820132)Yan Shi, Ying Wang, Wei Meng, et al.
Pageof 5